Professor Richard Hammond, who has been acting Chief Executive, will have responsibility for delivering clinical and commercial services for the University’s School of Veterinary Sciences.
Richard joined the University of Bristol as a Professor of Clinical Sciences and Deputy Head of School to support the implementation of the new curriculum and the management of the School. He then took on responsibility for enterprise and strategic development. Richard had formerly been part of the management team that set up the veterinary school at the University of Nottingham where he was also Head of Teaching and Learning.
Professor Hammond, commenting on his appointment said: “I am absolutely delighted to take up this position on a permanent basis. Langford Veterinary Services has an excellent track record of delivering high-quality clinical services in a commercially successful way, together with providing the learning environment needed for undergraduate and postgraduate clinical teaching and research.
"The sector faces some interesting challenges as well as some exciting opportunities. I look forward to leading Langford Vets into this new area, continuing to provide commercial success to support the highest quality teaching environment, whilst building on our clinical research potential to allow us to offer cutting-edge clinical services to our clients.”
Qualifying as a veterinary surgeon in 1991, Richard Hammond has a broad experience across clinical, academic and commercial sectors having previously been a specialist in the area of veterinary anaesthesia and an academic clinician. He was awarded a first class honours degree in applied biology in 1987, a degree in veterinary medicine in 1991, a PhD in 1999 in the area of biochemical pharmacology and a masters in medical education in 2012. He holds both Royal College of Veterinary Surgeons (RCVS) and European Diplomas in Veterinary Anaesthesia. As well as having experience of clinical general veterinary practice, Richard has worked as part of the commercial operation of a major pharmaceutical company.